Navigation Links
The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
Date:2/22/2011

er calcium, magnesium, and vitamin D as necessary.  Advise patients to contact a healthcare professional for symptoms of hypocalcemia.

ONJ can occur in patients receiving XGEVA. Patients who are suspected of having or who develop ONJ while on XGEVA should receive care by a dentist or an oral surgeon.  In these patients, extensive dental surgery to treat ONJ may exacerbate the condition.  

The most common adverse reactions in patients receiving XGEVA were fatigue/asthenia, hypophosphatemia, and nausea. The most common serious adverse reaction in patients receiving XGEVA was dyspnea.  The most common adverse reactions resulting in discontinuation of XGEVA were osteonecrosis and hypocalcemia.  Please visit www.xgeva.com for full prescribing information.

Denosumab is also marketed as Prolia® in other indications.

XGEVA Skeletal-Related Events Regulatory StatusXGEVA was approved by the FDA for the prevention of SREs in patients with bone metastases from solid tumors on Nov. 18, 2010. XGEVA is not indicated to prevent SREs in patients with multiple myeloma.

Administered as a single 120 mg subcutaneous injection every four weeks, XGEVA provides a new option for urologists and oncologists to prevent serious bone complications in men with prostate cancer.

Amgen has also submitted marketing applications for XGEVA in the European Union, Australia, Canada and Switzerland. In Japan, Amgen is working with its licensing partner, Daiichi-Sankyo Company, Limited and a marketing application was submitted.

Bone Metastases and Skeletal Related Events: Prevalence and Impact Bone metastases occur in more than 1.5 million patients with cancer worldwide and are most commonly associated with cancers of the prostate, lung, and breast, with incidence rates as high as 75 percent of patients with metastatic disease.(i)

Approximately 50-70 percent of cancer patients
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
6. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
7. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: ... employee Greg Watson , the company,s vice president of ... the company,s common stock, at a per share exercise price ... The stock option was granted pursuant to Cardica, Inc.,s Inducement ... in May 2015 under Rule 5653(c)(4) of the Nasdaq Global ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
... Oct. 11 Halozyme Therapeutics, Inc. (Nasdaq: ... targeting the extracellular matrix , today announced a ... programs through key clinical inflection points in 2011 and ... such as validation of Halozyme,s commercial scale manufacturing process ...
... China-Biotics to Attend BNP Paribas China Conference -- SHANGHAI, Oct. 11 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:Halozyme Therapeutics Announces Implementation of Development Focused Strategy 2Halozyme Therapeutics Announces Implementation of Development Focused Strategy 3Halozyme Therapeutics Announces Implementation of Development Focused Strategy 4China-Biotics to Attend BNP Paribas China Conference 2China-Biotics to Attend BNP Paribas China Conference 3China-Biotics to Attend BNP Paribas China Conference 4China-Biotics to Attend BNP Paribas China Conference 5China-Biotics to Attend BNP Paribas China Conference 6
(Date:5/22/2015)... Jupiter, FL (PRWEB) May 22, 2015 ... Ed Begley, Jr., scheduled to broadcast on Friday, May ... PST, via Discovery Channel. , In this episode Innovations ... companies get back to business quickly through disaster recovery ... NDPTC, a company that works collaboratively to develop and ...
(Date:5/22/2015)... May 22, 2015 Steven Winter Associates ... Zuluaga, has been selected by Consulting-Specifying Engineer (CSE) magazine ... winners are featured in the May/June issue of the ... industry professionals age 40 and younger who have, and ... as well as in other areas of their professional ...
(Date:5/22/2015)... 2015 A new program for the ... the field of Physical Therapy. , James Earl ... mystery out of physical therapy and discusses how the ... for a variety of ailments and injuries. Physical ... exercise plan that enhances daily activities such as house ...
(Date:5/22/2015)... 2015 In efforts to offer full ... containing particular muscles stretches has been a large focus ... stretches now complete, Chunk Fitness envisions a mid-June launch ... filmed and released at a later point in time. ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness ...
(Date:5/22/2015)... Viejo, CA (PRWEB) May 22, 2015 ... editable lower thirds designed exclusively for Final Cut Pro ... compatible with any design. , Intuitive on-screen-controls allow ... unique lower third. Reflections, colors, layouts, and much more ... Inspector window. , Pro3rd Impression comes ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... TUESDAY, May 17 (HealthDay News) -- A DNA region linked ... scientists. The studies by teams at Washington University School ... the United Kingdom pinpointed a region on chromosome 3 that ... analyzed data from 91 families in Australia and 25 families ...
... third-degree burns and other traumatic injuries endure pain, disfigurement, ... to grow back. Improved tissue grafts designed by Cornell ... healthy skin to invade the wounded area and reduce ... were engineered in the lab of Abraham Stroock, associate ...
... high-school students to surgeons, anyone who has pulled an all-nighter ... day: trouble focusing, a fuzzy memory and other cognitive impairments. ... the brain and the neurochemical basis for sleep deprivation,s effects ... in Penn,s School of Arts and Sciences and director of ...
... Reporter , TUESDAY, May 17 (HealthDay News) -- The ... and bones can also keep painful kidney stones at ... presenting data on Tuesday at the American Urological Association,s ... as diet, weight, calorie and calcium intake and medication ...
... By Maureen Salamon HealthDay Reporter , TUESDAY, ... harbor the human papillomavirus (HPV) responsible for cervical cancer ... means that boys as well as girls should get ... a small Austrian study, nearly a third of the ...
... at the University of Arizona College of Pharmacy found ... software systems the computer programs that are in ... correctly identified potentially dangerous drug-drug interactions. The study ... the research team tested the pharmacy software using a ...
Cached Medicine News:Health News:Gene Region Seems Linked to Depression 2Health News:Artificial tissue promotes skin growth in wounds 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 3Health News:What Protects the Heart May Also Ward Off Kidney Stones 2Health News:What Protects the Heart May Also Ward Off Kidney Stones 3Health News:Foreskin May Be Reservoir for HPV 2Health News:Foreskin May Be Reservoir for HPV 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: